CRYSTALLINE FORMS OF CFTR MODULATORS
Crystalline forms of Compound I: Formula (I) pharmaceutically acceptable salts thereof, and solvates and hydrates thereof are disclosed. Pharmaceutical compositions comprising the same, methods of treating cystic fibrosis using the same, and methods for making the same are also disclosed. L'inv...
Saved in:
Main Authors | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format | Patent |
Language | English French |
Published |
18.02.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Crystalline forms of Compound I: Formula (I) pharmaceutically acceptable salts thereof, and solvates and hydrates thereof are disclosed. Pharmaceutical compositions comprising the same, methods of treating cystic fibrosis using the same, and methods for making the same are also disclosed.
L'invention concerne des formes cristallines du composé I de formule (I), des sels pharmaceutiquement acceptables de celles-ci et des solvates et des hydrates correspondants. L'invention concerne également des compositions pharmaceutiques les comprenant, des procédés de traitement de la mucoviscidose à l'aide de celles-ci et des procédés de fabrication de celles-ci. |
---|---|
Bibliography: | Application Number: WO2020US46113 |